首页 > 市场调查报告书 > 医疗设备

体外诊断设备契约製造市场规模、份额和成长分析（按产品类型、技术、服务类型和地区划分）－2026年至2033年产业预测

市场调查报告书

商品编码

1900460

体外诊断设备契约製造市场规模、份额和成长分析（按产品类型、技术、服务类型和地区划分）－2026年至2033年产业预测

IVD Contract Manufacturing Market Size, Share, and Growth Analysis, By Product Type (Consumables, Equipment), By Technology (Immunoassays, Clinical Chemistry), By Service Type, By Region -Industry Forecast 2026-2033.

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 194 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，体外诊断设备 (IVD)契约製造市场规模将达到 184.4 亿美元，到 2025 年将达到 205.7 亿美元，到 2033 年将达到 495.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 11.6%。

体外诊断（IVD）契约製造市场预计将迎来显着成长，这主要得益于人们对个人化医疗、基因表现和生物标记发现日益增长的兴趣。这一趋势正在推动对标准化诊断解决方案的需求，尤其是在医疗成本持续上涨的新兴市场。数位病理学、次世代定序和先进成像等诊断技术的进步进一步推动了对创新诊断方法的需求。从个人化妊娠测试到复杂的临床检测，种类繁多的体外诊断产品正在推动市场动态。此外，製药业对体外诊断设备的日益普及以及对照护现场检测（POCT）的日益关注也促进了市场扩张。主要参与者之间的合作将在该行业的发展中发挥关键作用。

全球体外诊断（IVD）契约製造市场按产品类型、技术、服务类型和地区进行细分。依产品类型划分，可分为耗材和设备。依技术划分，可分为免疫检测、临床化学、分子诊断、血液学、微生物学、凝血与止血等技术。依服务类型划分，可分为生产服务、检测开发及其他服务。依地区划分，可分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

体外诊断契约製造市场的成长要素

糖尿病、癌症和心臟病等慢性疾病的日益流行，显着推动了对先进体外诊断（IVD）设备的需求。这种需求的激增，加上製造商为有效应对全球健康挑战而努力提高生产效率，共同推动了IVD契约製造市场的成长。在此背景下，契约製造製造商在为IVD公司提供高性价比、高品质的解决方案以及帮助其满足严格的监管要求方面发挥着至关重要的作用。随着医疗需求的不断演变，IVD公司与契约製造之间的合作变得日益重要，以确保创新诊断工具的供应，从而应对紧迫的健康问题。

体外诊断契约製造市场的限制

体外诊断（IVD）契约製造市场面临巨大的成本挑战。体外诊断医疗设备的研发和生产过程需要在研发、法规遵循和生产基础设施方面投入大量资金。这些高昂的成本会阻碍中小企业进入市场，使其难以进入，并阻碍整个产业的成长。因此，与创新和产能相关的财务负担会限制竞争和新技术的应用，从而影响体外诊断领域的市场动态和潜在发展。

体外诊断契约製造市场的发展趋势

体外诊断（IVD）契约製造市场的一大趋势是将生产外包给新兴市场，尤其是亚太地区。由于这些地区人事费用低廉且拥有大量熟练人才，能够实现高效的生产流程，企业正在加速向这些地区扩张。这种转变不仅有助于降低营运成本，也为製造商提供了机会，使其能够掌握快速成长市场对体外诊断产品日益增长的需求。因此，对高性价比生产解决方案和熟练劳动力的关注正在重塑体外诊断产业，并推动其成长和创新。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Jabil Inc.
Sanmina Corporation
TE Connectivity
Celestica, Inc.
West Pharmaceutical Services, Inc.
Savyon Diagnostics, Ltd.
KMC Systems
Cenogenics Corporation
Nova Biomedical
Cone Bioproducts
Kimball Electronics, Inc.
Roche Diagnostics
Viant Medical Holdings, Inc.
Sysmex Corporation
Stratec SE
Thermo Fisher Scientific, Inc.
Fujirebio
Biokit（Werfen）
Sekisui
Prestige Diagnostics

结论与建议

简介目录

Product Code: SQMIG35H2317

IVD Contract Manufacturing Market size was valued at USD 18.44 Billion in 2024 and is poised to grow from USD 20.57 Billion in 2025 to USD 49.51 Billion by 2033, growing at a CAGR of 11.6% during the forecast period (2026-2033).

The IVD contract manufacturing market is poised for significant growth, fueled by the rising focus on personalized medicine, gene expression, and biomarker discovery. This trend is propelling demand for standardized diagnostic solutions, particularly in emerging markets where healthcare costs continue to climb. Advancements in diagnostic technologies like digital pathology, next-generation sequencing, and advanced imaging are further driving the need for innovative diagnostics. A diverse array of in vitro diagnostics, from personalized pregnancy tests to complex clinical assays, enhances market dynamics. Additionally, the increasing adoption of IVD devices within the pharmaceutical sector and the rising interest in point-of-care monitoring contribute to the market's expansion. Collaboration among key players will play a crucial role in advancing this segment of the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the IVD Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

IVD Contract Manufacturing Market Segments Analysis

Global IVD Contract Manufacturing Market is segmented into Product Type, Technology, Service Type, and region. By Product Type, the market is classified into Consumables, and Equipment. Depending on the Technology, it is categorized into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, and Other Technologies. According to Service Type, the market is divided into Manufacturing Services, Assay Development, and Other Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the IVD Contract Manufacturing Market

The rising prevalence of chronic conditions like diabetes, cancer, and heart disease is significantly boosting the demand for sophisticated In Vitro Diagnostics (IVD) devices. This surge is propelling the growth of the IVD contract manufacturing market, as manufacturers strive to enhance productivity to tackle global health challenges effectively. In this context, contract manufacturers are essential in delivering cost-efficient, high-quality solutions to IVD companies, enabling them to comply with stringent regulatory requirements. As healthcare needs evolve, the partnership between IVD firms and contract manufacturers becomes increasingly vital in ensuring the availability of innovative diagnostic tools that address pressing health concerns.

Restraints in the IVD Contract Manufacturing Market

The IVD contract manufacturing market encounters notable challenges associated with costs. The process of developing and producing in vitro diagnostic devices demands substantial financial investments in research, regulatory compliance, and manufacturing infrastructure. Such elevated expenses can serve as a barrier for small and medium-sized enterprises, making it difficult for them to enter the market and hindering overall growth in the industry. Consequently, the financial burden of innovation and production capabilities may limit competition and the introduction of new technologies, affecting the market dynamics and potential advancements within the IVD sector.

Market Trends of the IVD Contract Manufacturing Market

The IVD Contract Manufacturing market is witnessing a significant trend towards outsourcing production to emerging markets, particularly in the Asia-Pacific region. Companies are increasingly attracted to these areas due to lower labor costs and the availability of skilled personnel, which facilitate efficient manufacturing processes. This shift not only helps reduce operational expenses but also allows manufacturers to leverage the burgeoning demand for in vitro diagnostic products in these fast-growing markets. As a result, the focus on cost-effective production solutions and access to a skilled workforce is reshaping the landscape of the IVD industry, driving growth and innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
Market Attractiveness Index
Supply Chain Analysis
Pricing Analysis

Global IVD Contract Manufacturing Market Size by Product Type & CAGR (2026-2033)

Market Overview
Consumables
Equipment

Global IVD Contract Manufacturing Market Size by Technology & CAGR (2026-2033)

Market Overview
Immunoassays
Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology
Coagulation & Hemostasis
Other Technologies

Global IVD Contract Manufacturing Market Size by Service Type & CAGR (2026-2033)

Market Overview
Manufacturing Services
Assay Development
Other Services

Global IVD Contract Manufacturing Market Size & CAGR (2026-2033)

North America, (Product Type, Technology, Service Type)
- US
- Canada
Europe, (Product Type, Technology, Service Type)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product Type, Technology, Service Type)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product Type, Technology, Service Type)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product Type, Technology, Service Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Jabil Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanmina Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TE Connectivity
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celestica, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Savyon Diagnostics, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KMC Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cenogenics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cone Bioproducts
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kimball Electronics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viant Medical Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stratec SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujirebio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biokit (Werfen)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prestige Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments